Jeff Yass’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SYRE
Jeff Yass's SYRE Position: Q3 2026 in Review
Jeff Yass increased its Spyre Therapeutics (SYRE) stake by 12% in Q3 2026, buying an estimated $436K and bringing the position to 43,849 shares worth $3.9M. The position accounts for ﹤0.01% of the portfolio, ranked #4893.
Jeff Yass first reported a position in SYRE in Q2 2017 and has held it in 19 quarters since. 286 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.
- Jeff Yass held 43,849 shares of Spyre Therapeutics worth $3.9M as of Q3 2026.
- Jeff Yass bought 4,538 Spyre Therapeutics shares in Q3 2026, an estimated $436K.
- Spyre Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #4893 holding.
- Jeff Yass first reported a position in Spyre Therapeutics in Q2 2017 and has held it in 19 quarters since.
- 286 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.